Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts.  Yang J, Landrum MB, Zhou L, Busch AB.  Gen Hosp Psychiatry. 2020 Nov-Dec;67:100-106. doi: 1…

The Impact of COVID-19 Pandemic on the Castile and Leon Addiction Treatment Network: A Real-Word Experience.  Roncero C, Vicente-Hernández B, Casado-Espada NM, Aguilar L, Gamonal-Limcaoco S, Garzón MA, Martínez-González F, Llanes-Álvarez C, Ma…

Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19.  Livingston NA, Ameral V, Banducci AN, Weisberg RB.  J Subst Abuse Treat. 2020 Dec 3:108…

Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19.  Joseph G, Torres-Lockhart K, Stein MR, Mund PA, Nahvi S.  J Subst Abuse Treat. 2020 Dec 3:108219. doi: 10.1016/j.jsat.2020.108219. E…

Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.  Dunn KE, Brooner RK, Stoller KB.  J Subst Abuse Treat. 2021 Feb;121:108197. doi: 10.1016/j.jsat.20…

COVID-19 and treating incarcerated populations for opioid use disorder.  Donelan CJ, Hayes E, Potee RA, Schwartz L, Evans EA.  J Subst Abuse Treat. 2020 Dec 2:108216. doi: 10.1016/j.jsat.2020.108216. Epub ahead of print. PMID: 33288348;…